Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Montreal General Hospital
Montreal, Quebec, Canada
- Ccop, Colorado Cancer Research Program, Inc.
Denver, Colorado, United States
- Ccop - Mount Sinai Medical Center
Miami Beach, Florida, United States
- Phoebe Putney Memorial Hospital
Albany, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Henry Ford Health System
Detroit, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Providence Hospital - Southfield
Southfield, Michigan, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Carolinas Medical Center/levine Cancer Center
Charlotte, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Albert Einstein Medical Center
Philadelphia, Pennsylvania, United States
- Allegheny General Hospital/allegheny-Singer Research Institute
Pittsburgh, Pennsylvania, United States
- Nsabp Foundation, Inc.
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Roper Hospital
Charleston, South Carolina, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Joe Arrington Cancer Research & Treatment Center
Lubbock, Texas, United States
- Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2012
- Primary completion
- 31 Mar 2014
- Completion
- 31 Oct 2015
- Last update posted
- 6 Oct 2021
- Registered enrollment
- 50
- Registry id
- NCT01705691
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.